Successful Treatment of Disseminated Acanthamoeba Infection in an Immunocompromised Patient

Cathy A. Slater, Joshua Z. Sickel, Govinda S. Visvesvara, Rufino C. Pabico, Anthony A. Gaspari

New England Journal of Medicine · 1994 · 119 citations · 14 references

DOIFull text

Open access

Concepts

Abstract

Disseminated acanthamoeba infection, an amebic infection characterized by granulomatous infiltrates in the brain and skin, usually occurs in immunocompromised or debilitated patients and generally progresses to death. There has been no effective therapy. We report on a patient who had undergone renal transplantation and was receiving triple immunosuppressive therapy when widespread granulomatous skin lesions caused by Acanthamoeba rhysodes developed. Antimicrobial therapy was initiated with a four-week course of intravenous pentamidine isethionate, topical chlorhexidine gluconate, and 2 percent ketoconazole cream. The result was a dramatic improvement in the skin lesions. Cyclosporine levels remained stable, but therapy was complicated by signs of . . .

References

14